CORRESP 1 filename1.htm
Daxor Corporation
350 Fifth Avenue, Suite 4740
New York, NY 10118
August 17, 2018
Via EDGAR
United States
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Daxor Corporation – Registration Statement on Form N-2
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned Registrant hereby requests that the above-referenced Registration Statement be declared effective on August 17, 2018, or as soon as is practicable thereafter. For purposes of Rule 461, there is no underwriter at this time.
Very truly yours,
| DAXOR
CORPORATION | |
| --- | --- |
| By: | /s/ John Wilkens |
| Name: | John Wilkens |
| Title: | Chief Financial Officer |
Field: Page; Sequence: 1
Field: /Page